Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide-Reference-Cited by-同舟云学术

Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

Published:2020-11 Issue:3 Volume:108 Page:716-724
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Rahman Rifaquat,Trippa Lorenzo,Alden Stephanie,Fell Geoffrey,Abbasi Taher,Mundkur Yatin,Singh Neeraj K.,Talawdekar Anay,Husain Zakir,Vali Shireen,Ligon Keith L.,Wen Patrick Y.,Alexander Brian M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference33 articles.

1. Malignant gliomas in adults;Wen;N Engl J Med,2008

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. From the core to beyond the margin: A genomic picture of glioblastoma intratumor heterogeneity;Aubry;Oncotarget,2015

4. Molecular tumor boards: Current practice and future needs;van der Velden;Ann Oncol,2017

5. Precision oncology: An overview;Garraway;J Clin Oncol,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy;ESMO Gastrointestinal Oncology;2024-03

2. The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening;Scientific Reports;2024-02-14

3. Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers;International Journal of Molecular Sciences;2023-09-19

4. The Temozolomide-Doxorubicin paradox in Glioblastoma in vitro-in silico preclinical drug-screening;2023-08-21

5. Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference;The Lancet Oncology;2023-04